Teva Pharmaceuticals
TEVA
TEVA
537 hedge funds and large institutions have $11.2B invested in Teva Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 73 funds opening new positions, 193 increasing their positions, 171 reducing their positions, and 59 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
12% more funds holding in top 10
Funds holding in top 10: 25 → 28 (+3)
2.32% more ownership
Funds ownership: 53.66% → 55.98% (+2.3%)
2% more funds holding
Funds holding: 529 → 537 (+8)
Holders
537
Holding in Top 10
28
Calls
$498M
Puts
$175M
Top Buyers
| 1 | +$374M | |
| 2 | +$136M | |
| 3 | +$85.3M | |
| 4 |
William Blair Investment Management
Chicago,
Illinois
|
+$78.3M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$44.1M |
Top Sellers
| 1 | -$118M | |
| 2 | -$65.8M | |
| 3 | -$54.3M | |
| 4 |
PF
Phoenix Financial
Givatayim,
Israel
|
-$51.6M |
| 5 |
Truist Financial
Charlotte,
North Carolina
|
-$45M |